Drug-Associated Rhabdomyolysis in the FDA Adverse Event Reporting System (FAERS): A Disproportionality Analysis
arXiv:2511.00093v2 Announce Type: replace Abstract: This study aimed to systematically identify and quantify risks for drug-induced rhabdomyolysis (DIR) using real-world data and to propose an evidence-based risk mitigation framework.